Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |